Femtech 市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Femtech Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年10月03日 | 出版商:

Global Market Insights Inc. | 英文 131 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球女性科技市场价值为 551 亿美元，预计 2024 年至 2032 年将以 12.8% 的年复合成长率(CAGR) 扩大。上升推动的。癌症、糖尿病、高血压和精神健康障碍等慢性疾病以及爱滋病毒和结核病等传染病的显着增加对女性人口产生了重大影响。这种日益增加的负担凸显了迫切需要针对这些紧迫的健康问题量身定制有效的医疗保健解决方案。女性科技市场分为产品、软体和服务。

2023 年，软体领域成为领先者，创造了 2,850 万美元的收入。人们对女性健康的日益认识，特别是在以前被忽视的领域，如月经和生殖健康，是这一领域增长的主要推动力。每个月都有月经週期的大量育龄妇女进一步强调了该市场的创新和发展潜力。从应用来看，女性科技市场涵盖生殖健康、怀孕保健、孕产妇/产后及护理、身心综合健康、整体福祉等领域。

2023 年，生殖健康领域占据主导地位，占 43.8% 的市场。在教育措施和社会运动的推动下，人们对女性独特的健康挑战（包括生育、月经、怀孕和更年期）的认识大幅提高。这种意识的提高培养了更知情的消费者群体，渴望获得专门的生殖健康解决方案。 2023 年，北美女性科技市场收入为178 亿美元，预计2024 年至2032 年复合年增长率为13%。。许多女性表示，由于成本问题而推迟或放弃医疗保健，这表明市场对更容易获得的解决方案的巨大需求。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	551 亿美元
预测值	1,359 亿美元
复合年增长率	12.8%

产业生态系统分析
产业影响力
- 成长动力
  - 已开发国家利用数位科技管理女性健康
  - 改善偏远地区妇女获得照护的机会
  - 发展中国家对妇女健康和保健的认识不断提高
  - 女性人口中慢性病和传染病的负担日益增加
  - 女性科技业投资不断增加
- 产业陷阱与挑战
  - 对女性科技产品与应用缺乏认识
成长潜力分析
监管环境
- 我们
- 欧洲
- 亚太地区
技术景观
未来市场趋势
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按类型，2021 - 2032

主要趋势
产品
软体
服务

第 6 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
生殖健康
- 月经週期和生育能力
  - 避孕
  - 妊娠检测
  - 生育力测试和受孕支持
  - 循环监控
  - 生殖健康指导
- 停经
孕期护理
- 怀孕进展洞察应用程式
- 怀孕交流网络及家长教育
- 孕期健康指导
- 堕胎和流产支持
产妇/产后及护理
- 产后支持
- 母乳哺育与哺乳支持
- 个人发展
身心健康及整体福祉
- 疼痛缓解和管理
- 怀孕健康监测
- 父母健康
- 疾病预防与检测
其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
直接面向消费者
医院
生育诊所
手术中心
诊断中心
其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 俄罗斯
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 中东和非洲其他地区

第 9 章：公司简介

Amazon.com, Inc.
AVA Women
Clue (BioWink GmbH)
Conceivable
Daysy (Valley Electronics AG)
Elvie (Chiaro Technology Ltd.)
Flo Health Inc.
Google Nest (Alphabet Inc.)
HeraMED Limited
LactApp Women's Health SL
LunaJoy
MASIMO CORPORATION
Maven Clinic
Nanit
Natural Cycles
Peppy Health Limited
Preglife
Pregnancy+ (Koninklijke Philips NV)
Soula - AI (Mamatech Ltd.)
Univfy Inc.

简介目录

Product Code: 4442

The Global Femtech Market was valued at USD 55.1 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 12.8% from 2024 to 2032. This growth is primarily fueled by the increasing prevalence of chronic and infectious diseases affecting women. A notable rise in chronic health conditions such as cancer, diabetes, hypertension, and mental health disorders, along with infectious diseases like HIV and tuberculosis, has had a significant impact on the female population. This growing burden highlights the urgent need for effective healthcare solutions tailored to address these pressing health issues. The femtech market is categorized into products, software, and services.

In 2023, the software segment emerged as the leader, generating USD 28.5 million in revenue. The growing recognition of women's health, particularly in previously overlooked areas such as menstrual and reproductive health, is a major driver of growth in this segment. The substantial number of women of reproductive age experiencing menstrual cycles each month further emphasizes the potential for innovation and development within this market. In terms of application, the femtech market encompasses reproductive health, pregnancy care, maternal/postpartum and nursing care, integrative physical and mental health, and overall well-being.

The reproductive health segment dominated in 2023, capturing 43.8% of the market share. Increased awareness surrounding women's unique health challenges-including fertility, menstruation, pregnancy, and menopause-has surged, largely driven by educational initiatives and social movements. This heightened awareness has cultivated a more informed consumer base eager to access specialized reproductive health solutions. North America accounted for USD 17.8 billion in femtech market revenue in 2023, with a projected growth rate of 13% CAGR from 2024 to 2032. This growth is driven by rising awareness of women's health issues and the benefits of femtech innovations.Women are continuously seeking individualized, available, and effective healthcare alternatives. Many women have reported delaying or forgoing healthcare due to cost concerns, indicating a significant demand for more accessible solutions in the market.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$55.1 Billion
Forecast Value	$135.9 Billion
CAGR	12.8%

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Usage of digital technology to manage women health in developed countries
  - 3.2.1.2 Improving access to women care in remote areas
  - 3.2.1.3 Growing awareness regarding women health and wellness in developing countries
  - 3.2.1.4 Increasing burden of chronic and infectious diseases among the female population
  - 3.2.1.5 Growing investments in femtech industry
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Lack of awareness about femtech products and applications
3.3 Growth potential analysis
3.4 Regulatory landscape
- 3.4.1 U.S.
- 3.4.2 Europe
- 3.4.3 Asia Pacific
3.5 Technological landscape
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Product
5.3 Software
5.4 Services

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Reproductive health
- 6.2.1 Menstrual cycle & fertility
  - 6.2.1.1 Contraception
  - 6.2.1.2 Pregnancy testing
  - 6.2.1.3 Fertility testing & conception support
  - 6.2.1.4 Cycle monitoring
  - 6.2.1.5 Reproductive health guidance
- 6.2.2 Menopause
6.3 Pregnancy care
- 6.3.1 Pregnancy progress insights apps
- 6.3.2 Pregnancy exchange network & parental education
- 6.3.3 Pregnancy health guidance
- 6.3.4 Abortion & miscarriage support
6.4 Maternal/postpartum and nursing care
- 6.4.1 Postpartum support
- 6.4.2 Breastfeeding & lactation support
- 6.4.3 Personal development
6.5 Integrative physical and mental health & overall well-being
- 6.5.1 Pain relief and management
- 6.5.2 Pregnancy health monitoring
- 6.5.3 Parental health
- 6.5.4 Disease prevention and detection
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Direct-to-consumer
7.3 Hospitals
7.4 Fertility clinics
7.5 Surgical centers
7.6 Diagnostic centers
7.7 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Russia
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East and Africa